SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001144204-17-006649
Filing Date
2017-02-08
Accepted
2017-02-08 10:53:44
Documents
1
Effectiveness Date
2017-02-08

Document Format Files

Seq Description Document Type Size
1 DEFM14A v458707_defm14a.htm DEFM14A 1460740
  Complete submission text file 0001144204-17-006649.txt   1461863
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35076 | Film No.: 17581324
SIC: 2835 In Vitro & In Vivo Diagnostic Substances